Clinical Trials Directory

Trials / Completed

CompletedNCT01063608

Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Medical Staff.

Study of Immune Responses After Vaccination Against Seasonal Influenza Virus and Against Influenza H1N1-v Pandemic Virus in a Clinical Staff (FLU-HOP)

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
147 (actual)
Sponsor
Institut National de la Santé Et de la Recherche Médicale, France · Other Government
Sex
All
Age
20 Years
Healthy volunteers
Accepted

Summary

This project may help to answer several fundamental questions related to public health regarding vaccination against influenza viruses and regarding the influenza A(H1N1)v pandemy: What is the immunologic efficacy in terms of antibodies response of the vaccination against the seasonal (2009-2010) influenza virus and against the A(H1N1)v virus in the clinical staff? Moreover, it may help to answer questions related to the use of a vaccine against influenza virus variants emerging in the French population: 1. Before the vaccination: * What is the status of the residual anti-H1N1 seasonal viruses immunity and of the anti-A(H1N1)v immunity in the population stratified by age and taking into account the multiplicity of the prior seasonal vaccinations? * What is the level of the cellular and humoral cross-reactivity between the different H1N1 strains? 2. After the vaccination: * What is the intensity of the anti-vaccine immune response as a function of the age of the population ad of the prior seasonal vaccinations? * What is the level of the cellular and humoral cross-reactivity after vaccination as a function of the age of the population and of the multiplicity of the prior seasonal vaccinations?

Conditions

Interventions

TypeNameDescription
BIOLOGICALAnti-H1N1v VaccineInclusion of hospital personnel in the context of the anti-H1N1v prophylaxy plan.

Timeline

Start date
2009-10-01
Primary completion
2009-12-01
Completion
2010-05-01
First posted
2010-02-05
Last updated
2025-09-04

Locations

2 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01063608. Inclusion in this directory is not an endorsement.